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Abstract. Selenium is an essential trace element. In cat-
tle, selenium deficiency causes dysfunction of various 
organs, including skeletal and cardiac muscles. In hu-
mans as well, lack of selenium is associated with many 
disorders, but despite accumulation of clinical reports, 
muscle diseases are not generally considered on the list. 
The goal of this review is to establish the connection be-
tween clinical observations and the most recent advances 
obtained  in  selenium  biology.  Recent  results  about  a 
possible role of selenium-containing proteins in muscle 
formation and repair have been collected. Selenoprotein 
N is the first selenoprotein linked to genetic disorders 
consisting of different forms of congenital muscular dys-
trophies. Understanding the muscle disorders associated 
with selenium deficiency or selenoprotein N dysfunction 
is an essential step in defining the causes of the disease 
and obtaining a better comprehension of the mechanisms 
involved in muscle formation and maintenance.
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Introduction
Discovered in 1817 by Berzelius, selenium was consid-
ered originally and for a long time as a vicious poison. It is 
only in the mid-1950s that the physiological significance 
of this trace element was correctly evaluated. Identifica-
tion of pathologies related to selenium deficiencies dem-
onstrated its essential nutrient function, first in livestock 
and next in humans [1]. Since then, compiling evidence 
has shown the importance of selenium in prevention of 
cancer, cardiovascular diseases and viral infections, as 
well as thyroid and immune system functions, fertility 
and aging (reviewed in [2–4]). The multiplicity of the 
diseases, and the absence of evident link between them, 
suggested that selenium is involved in multiple biologi-
cal processes. Biochemistry and molecular biology have 
contributed to deciphering these activities by determin-
ing the molecular mechanisms in which this compound 
is involved.
Primarily, biochemical studies identified selenocysteine 
as the major biological form of selenium in animals and 
bacteria. This particular amino acid is specifically incor-
porated into selenoproteins through a dedicated transla-
tion machinery [5]. Using genomics and bioinformatics 
data mining, the almost complete repertoire of seleno-
proteins was identified in both animals and bacteria ([6, 
7] and for a review see [8]). Twenty-six different seleno-
proteins were identified in higher eukaryotes, though the 
function of many of them remains unknown (table 1). 
Selenoproteins of known function are all oxidoreductase 
intervening enzymes, implicated in multiple metabolic 
pathways,  e. g.,  free  radical  scavenging,  maintenance 
of intracellular redox status, repair of oxidized lipids or Cell. Mol. Life Sci. 63 (2006) 52–59
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methionines. Other selenoproteins are involved in thy-
roid hormone metabolism, selenocysteine synthesis or in 
different steps of sperm maturation. In all documented 
cases, selenocysteine was shown to take part directly in 
the catalytic reaction. Selenocysteine functions as an ex-
traordinarily reactive cysteine homologue. This increased 
reactivity is usually regarded as the ‘raison d’être’ for se-
lenoproteins, despite their costly and inefficient synthesis 
machinery ([9] and references included).
Up to now, only a few molecular mechanisms have been 
demonstrated that establish direct links between seleno-
protein dysfunctions and the diseases caused by selenium 
deprivation. Among unexplained deficiencies are differ-
ent forms of muscular diseases whose conditions remain 
elusive (reviewed in [10]). Older observations together 
with recent findings demonstrated a clear role for sele-
nium and certain selenoproteins in muscle physiology 
and their implication in muscular diseases (table 2).
Table 1. Selenoproteins identified in eukaryotes.
Seleno-  Chromosomal   Catalytic function  Schematic representation
protein  location in 
  humans
15kDa  1p22.3    involved in the protein folding control within the endoplasmic 
reticulum
DI1  1p32.3  thyroid hormone maturation
DI2  14q31.1  thyroid hormone maturation
DI3  14q32  thyroid hormone catabolism
GPx1  3p21.31  cytoplasmic, free-radical reduction
GPx2  14q23.3  plasmatic, free-radical reduction
GPx3  5q33.1    gastrointestinal, free-radical reduction
GPx4  19p13.3    oxidized phospholipid reduction and chromatin condensation 
during spermatogenesis
GPx6  6p22.1    free-radical reduction, selenocysteine in pig and man only, 
highly expressed in olfactory epithelium
H  11q12.1  unknown
I  2p23.3  unknown
J  –    unknown, present in fishes and sea urchin, cysteine homologues 
in jellyfishes
K  3p21.31  unknown
M  22q12.2  unknown
N  1p35.36    unknown, associated to muscular diseases, localized in the 
endoplasmic reticulum membrane
O  22q13.33  unknown
P  5p12    nitrite reductase and plasmatic selenium transport
S  15q26.3    unknown, localized in the endoplasmic reticulum membrane
SPS2  16p11.2    selenophosphate synthetase, selenocysteine metabolism
T  3q24  unknown
TR1  12q23.3  cytoplasmic
      thioredoxin reductase
TR2  3q21.2    mitochondrial 
    thioredoxin reductase
TR3  22q11.21    thioredoxin/glutathione reductase, disulfide isomerase, 
important for sperm maturation
U  –    unknown, selenocysteine in fish, birds, sea urchins, green algae 
and diatoms only
V  19q13.13    unknown, highly expressed in testis
W  19q13.32    unknown, associated with cardiac calcification
MsrA  –    methionine-S-sulfoxide reductase, selenocysteine in C. 
reinhardtii only
MsrB   16p13.3  methionine-R-sulfoxide reductase
(X/R)
Human chromosomal locations and characterized functions are indicated. The relative position of the selenocysteine residue is indicated 
by a dark box. DI: iodothironine deiodinase; GPx: glutathione peroxidase.
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J - Unknown, present in fishes and sea urchin, cysteine 
homologues in jellyfishes
K 3p21.31 Unknown
M 22q12.2 Unknown
N 1p35.36 Unknown, associated to muscular diseases, 
localized in the endoplasmic reticulum membrane
O 22q13.33 Unknown
P 5p12 Nitrite reductase and plasmatic selenium transport
S 15q26.3 Unknown, localized in the endoplasmic reticulum 
membrane
SPS2 16p11.2 Selenophosphate synthetase, selenocysteine 
metabolism
T 3q24 Unknown
TR1 12q23.3 Cytoplasmic 
Thioredoxin Reductase
TR2 3q21.2 Mitochondrial 
Thioredoxin Reductase
Redox enzymes 
involved in 
multiple 
biosynthetic
pathways and 
regulation 
mechanisms
TR3 22q11.21 Thioredoxin/Glutathione Reductase, disulfide 
isomerase, important for sperm maturation
U - Unknown, selenocysteine in fish, birds, sea urchins, 
green algae and diatoms only
V 19q13.13 Unknown, highly expressed in testis
W 19q13.32 Unknown, associated with cardiac calcification
MsrA - Methionine-S-sulfoxide reductase, selenocysteine 
in C.reinhardtii only
MsrB (X/R) 16p13.3 Methionine-R-sulfoxide reductase 
2
3
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The importance of selenium in muscle physiology
Shortly after selenium acquired the status of essential 
trace  element,  dispersed  publications  reported  its  im-
portant role in muscle function. A lack of selenium as-
sociated with several muscular diseases affecting both 
cardiac and skeletal muscles was described in both cattle 
and humans, defining a new syndrome called nutritional 
muscular  dystrophy  [11–14].  White  muscle  disease 
(WMD) in cows, calves and sheep, or rigid/stiff lamb 
syndrome  (RL)  are  myopathies  characterized  by  the 
alteration of cardiac and skeletal muscle fibers with ex-
tensive calcification as an often-observed feature. Emer-
gence of these diseases is strongly influenced by diet, and 
a direct link between the selenium content of the food 
and the incidence of the diseases could be established 
[15, 16]. Finally, a good protection against WMD or RL 
emergence by selenium supplementation demonstrated 
the importance of this trace element.
In humans, Keshan disease is another selenium-related 
disorder occurring in different regions of eastern China 
where the selenium content of the soil is very low (for 
review, [17]). This disease corresponds to a cardiomy-
opathy, characterized by necrotic lesions, inflammatory 
areas and calcification throughout the myocardium [18]. 
Experimental  approaches  in  mouse  suggested  a  dual 
etiology for the disease. It is caused by both a dietary 
deficiency in the trace element and an infection by a non-
virulent strain of the enterovirus Coxsackie. The virus 
became  virulent  after  passage  in  a  selenium-deficient 
host [19]. Mutations occurred in the genome of the harm-
less viral strain, turning it into a cardiovirulent one. The 
pathogenicity  and  irreversibility  of  the  mutation  were 
demonstrated as the modified viral strain also provoked 
heart  damage  in  adequate  selenium  mice.  Moreover, 
identical results were obtained from a glutathione peroxi-
dase knockout mouse strain, indicating the essentiality of 
this selenoenzyme to prevent the oxidative mutations of 
the viral genome [20].
Prolonged parenteral nutrition is another cause for severe 
selenium deficiency associated with skeletal muscle dis-
orders [21–23]. A lower glutathione peroxidase activity, 
indicative of the low cellular selenium status, was asso-
ciated with muscle pain and weakness. In these cases, 
the  affected  patients  responded  favorably  to  selenium 
administration  [24].  The  effects  of  selenium  adminis-
tration were also tested in patients featuring myotonic 
dystrophies, since it was observed that their selenium 
Table 2. Overview of Human and animal muscular disorders provoked by selenium or selenoprotein deprivation.
  Disease  Conditions  Symptoms  References
       
In humans  Keshan disease   low selenium diet and   cardiomyopathy: necrotic lesions, inflammatory   17, 18
    Coxsackie virus infection  areas, calcification through myocardium
  Nutritional myotonic   low selenium diet  muscle pain and weakness  24–26
  dystrophy
  Nutritional myotonic   parenteral or enteral   muscle pain and weakness  21–23
  dystrophy  nutrition
  Chronic muscle   alcohol  muscle pain and weakness  29, 30
  disorder associated   HIV infection
  with oxidative stress
  Rigid spine muscular       31, 32, 46
  dystrophy   
  Multiminicore disease      48
  Mallory body-like   mutations in the   hypotonia, predominance of axial muscle   55
  desmin-related   selenoprotein N gene  weakness, scoliosis, sarcomeric disorganization,…
  myopathy
  Dropped head       58
  syndrome
In animals  Nutritional muscular   low selenium diet  cardiac and skeletal muscle affections  11–14
  dystrophy (chicken, 
  turkey, salmon,…)
  White muscle  low selenium diet inducing    alterations of cardiac and skeletal muscles,   15, 41
    disease (calf)low concen-  extensive calcification
    tration in selenoprotein W
  Rigid lamb   combined selenium and   rigidity of the limbs and spine  16
  syndrome  vitamin E deficiency
  Fatal myopathy   combined selenium and   muscle affection, lipid peroxidation,   36
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level in blood decreased with the evolution of the disease 
[25]. Even if no positive effects of selenium administra-
tion could be generally observed, one myotonic dystro-
phy patient presented an improvement of his muscular 
strength in parallel with the diminution of the pathologi-
cal symptoms [26]. Conversely, supplementation studies 
in the case of Duchenne or Becker human muscular dys-
trophies did not show improvement, suggesting they may 
not be selenium-linked [27, 28]. Different responses to 
selenium administration in muscular dystrophic patients 
suggested  different  etiologies.  In  isolated  cases,  mito-
chondrial alterations were described in muscle biopsies 
from  patients  presenting  muscle  disorders  associated 
with selenium deficiency, and a possible connection to 
oxidative damage was suggested ([29, 30] and for a re-
view see [10]).
More  direct  evidence  establishing  the  connection  be-
tween muscle dysfunction and selenium was obtained 
as the group of Guicheney demonstrated that a form of 
congenital muscular dystrophy is caused by mutations in 
a gene encoding a newly characterized selenium-contain-
ing protein, the selenoprotein N [31–33].
A conflicting connection to vitamin E
Vitamin E/tocopherol deficiency is often linked to se-
lenium  deficiency.  Actually,  the  simultaneous  lack  of 
selenium  and  vitamin  E  is  the  cause  of  most  known 
syndromes. The first studies, aimed at reproducing these 
diseases under controlled feeding conditions, failed to es-
tablish any relation between the tocopherol content and 
WMD occurrence, contrary to what was observed for se-
lenium. Nonetheless, incidence of rigid lamb syndrome 
was lowered by simultaneous administration of selenium 
and vitamin E to ewes [15]. Other studies indicated a 
more important role for vitamin E. For instance, when us-
ing a diet low in selenium only, a less marked incidence 
of the disease was observed [34]. A French group could 
even  separate  the  two  deficiencies  to  obtain  distinct, 
although  clinically  related  myopathies  [35].  Finally,  a 
study demonstrated that combined selenium and vitamin 
E deficiencies resulted in systemic fatal myopathy in the 
guinea pig, whereas the pathology was much less severe 
in the case of single deficiency [36]. In the affected mus-
cles, lipid peroxidation was observed and associated with 
a decrease in glutathione peroxidase activity, probably 
reflecting the lack of selenium. It was also shown that no 
myopathy occurred in calves when the diet was low in 
selenium, adequate in tocopherol and low in polyunsatu-
rated fatty acids [37].
Therefore, vitamin E appears as a factor exacerbating the 
lack in selenium, but the mechanism is not understood. 
Indeed, the complete panel of functions of vitamin E is 
not known yet. Its antioxidative properties suggest that it 
is involved in prevention of oxidative stress, but vitamin 
E functions are clearly undervalued, and this molecule 
might be involved in more specific reactions remaining 
to be characterized (for a review, see [38]).
Selenoproteins in muscle tissue
Since selenium is incorporated into proteins in the form of 
selenocysteine, muscular selenoproteins were investigated 
in animals affected with WMD. After administration of 
75Se to lambs, radioactive muscle proteins were analyzed, 
allowing identification of the selenoprotein W [39, 40]. 
Selenoprotein W is a protein present at high level in mus-
cles  from  selenium-supplemented  animals,  but  almost 
undetectable in those presenting WMD (table 1) [41]. The 
sarcoplasmic reticulum in the muscle of WMD animals 
has lost its ability to sequester calcium, resulting in the 
calcification of both skeletal and cardiac muscle tissues 
[42]. The direct implication of selenoprotein W in this 
process remains to be established since the overall level of 
most selenoproteins in the muscle might be lowered in the 
case of selenium deficiency, and the precise function of se-
lenoprotein W has yet to be elucidated. It was reported that 
selenoprotein W both binds glutathione [43] and shows 
glutathione-dependent antioxidant activity in vivo [44]. 
Selenoprotein N, the missing link
Identification of novel selenoproteins through bioinfor-
matic approaches provided new paths to the identifica-
tion of physiological disorders associated with selenium 
deficiency. Among the new proteins is selenoprotein N, a 
protein of unknown function [33, 45]. Its gene, SEPN1, 
was localized on chromosome 1 at position p35-36 (ta-
ble 1). This position corresponds to the locus associated 
with rigid spine muscular dystrophy (RSMD) [31]. This 
is a rare congenital muscular disease characterized by 
early onset of hypotonia, predominance of axial muscle 
weakness leading to life-threatening respiratory insuffi-
ciency and scoliosis (table 2) [46]. This locus was further 
restricted to a region containing about 20 genes, includ-
ing the selenoprotein N gene. According to the multiple 
observations supporting the role of selenium in muscle 
physiology,  the  SEPN1  gene  appeared  to  be  a  good 
candidate for RSMD. Indeed, sequencing of the SEPN1 
gene from affected patients identified several mutations 
in different families [32], establishing for the first time a 
connection between a selenoprotein and a human genetic 
disorder. However, the precise role of selenoprotein N 
in the muscle must be further investigated, since its bio-
chemical function remains unknown.
Based on convergent clinical and morphological infor-
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timinicore disease (MmD) and selenoprotein N was also 
assumed. MmD is a heterogeneous congenital myopathy 
from which four subgroups can be distinguished. The 
moderate form of MmD is provoked by mutations in the 
ryanodine receptor type 1 gene [47]. For the other three 
forms, among which the most current and severe is called 
classical MmD, the causative genes were unknown. The 
analysis of 27 informative families with MmD showed a 
linkage to the RSMD1 locus for 8 of them, featuring the 
classical form of the disease [48]. Sequencing the SEPN1 
gene in the 8 families linked to the RSMD1 locus and 
in 14 additional sporadic patients featuring the classical 
phenotype identified 9 possible mutations. Three of them 
were previously described in RSMD patients, and 6 were 
totally new ones. These studies contributed to the defini-
tion of a selenoprotein N-related myopathy class.
In another heterogeneous group of muscle disorders, the 
desmin-related myopathies or desminopathies (DRMs), 
no responsible gene was assigned for two-thirds of the 
cases [49, 50]. These diseases are characterized by ac-
cumulation  of  desmin  and  different  other  protein  ag-
gregates into the cytoplasm of muscle fibers [51, 52]. 
In 30 % of the cases, a mutation in the desmin gene was 
proven to be responsible for the disease [49, 50]. In an-
other family, a mutation in the a-b crystallin gene was 
identified for the same disease [53, 54]. The latter disease 
is now also called a-b crystallinopathy. In an alternative 
form of the disease, MB-DRM, featuring Mallory body-
like inclusions, the causative gene was not determined. 
The presence of similar inclusion bodies in two cases 
of selenoprotein N-related myopathies suggested a link 
between  MB-DRM  and  selenoprotein  N.  Analysis  of 
four  MB-DRM  patients  of  the  same  German  family 
demonstrated a relationship between the disease and the 
selenoprotein N locus, pointing at a new selenoprotein N 
gene deletion [55]. This interesting finding illustrates the 
heterogeneity of DRM, and increases the broad spectrum 
of the selenoprotein N-related myopathies. Since these 
initial characterizations, more reports on novel mutations 
in selenoprotein N gene have been collected from differ-
ent patients presenting early onset myopathy [56–58].
One striking conclusion of these findings resides in the 
fact that mutations in the SEPN1 gene are the condition 
for three different but related forms of congenital muscu-
lar dystrophy. The congenital muscular dystrophies are a 
clinically and genetically heterogeneous group of inher-
ited neuromuscular disorders. Each form presents a char-
acteristic, sometimes overlapping-phenotype, and their 
classification is based on a combination of clinical de-
scriptions and characterized protein defects (for a review, 
see [59]). Concerning SEPN1, the different mutations do 
not appear to be specific to each pathological form as sev-
eral mutations are shared by RSMD, MmD or MB-DRM 
disorders. This observation suggests that the three enti-
ties actually consist of different expressions of the same 
disease and that Selenoprotein N dysfunction has a large 
myopathological spectrum depending on other genetic or 
environmental factors. The hallmark of these diseases is 
a predominant affection of the axial muscle, leading to 
severe scoliosis and respiratory insufficiency [55]. The 
principal property of these muscles consists in their con-
stant tonic contraction in order to sustain the permanent 
posture, possibly involving specific mechanical or physi-
ological constraints connected to selenoprotein N cel-
lular function. At the microscopic level, a defect of this 
protein appears to cause focal sarcomere disorganization, 
mitochondria depletion (mini-cores) and abnormal ac-
cumulation of multiple filamentous proteins, including 
desmin,  within  cytoplasmic  foci.  Further  insight  into 
selenoprotein N function is therefore the next milestone 
to reach for better understanding the conditions allowing 
the development of the diseases.
For  the  moment,  biochemical  data  have  demonstrated 
that selenoprotein N is a 65-kDa transmembrane glyco-
protein localized within the endoplasmic reticulum [60]. 
This subcellular compartment plays different important 
roles relevant to muscular function: calcium sequestra-
tion and controlled release during contraction; connec-
tion to the cytoskeleton; synthesis, folding and glyco-
sylation of membrane or membrane-associated proteins 
involved  in  cell-to-cell  adhesion  (for  a  review,  [61]). 
Which  of  these  pathways  selenoprotein  N  is  involved 
in, is presently unknown. Several genes, the products of 
which are involved in post-translational modification of 
proteins, were shown to be the targets of mutations caus-
ing other forms of congenital muscular dystrophies, such 
as Walker-Warburg syndrome, muscle-eye-brain disease 
and Fukuyama muscular dystrophy. The corresponding 
enzymes, POMT1/POMT2, POMGnT1, Fukutin, FKRP 
and the protein LARGE, have activity related to protein 
O-mannosylation and glycosylation pathways. They are 
located either within the endoplasmic reticulum or the 
cis-Golgi apparatus (for reviews, see [59, 62]). Deficien-
cy in post-translational modification of a-dystroglycan 
is a common feature of these muscular diseases. This 
abnormally modified a-dystroglycan is deficient in bind-
ing  to  extracellular  matrix  ligands,  including  laminin/
merosin and agrin, and is therefore believed to disrupt the 
trans-sarcolemmal linkage between the actin membrane 
cytoskeleton and the extracellular matrix. Thus, impaired 
a-dystroglycan  affects  the  mechanical  and  probably 
also the signaling linking properties between cells, and 
therefore is likely to cause rupturing of the destabilized 
surface membrane in muscle fibers [63, 64]. A possible 
role for selenoprotein N in another related protein modi-
fication mechanism remains to be uncovered.
Genomic studies identified a protein homologous to se-
lenoprotein N in all vertebrates and even in their close 
ancestor,  the  ascidian  Ciona  intestinalis.  However,  no 
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eukaryotes, making this gene a singularity of the chor-
date phylum. Moreover, the protein sequence is highly 
conserved through evolution. Analysis of the expression 
pattern of the selenoprotein N gene revealed that it is 
ubiquitously expressed in all tissues examined, an obser-
vation difficult to reconcile with the muscle-specific phe-
notype associated with mutations in the gene. However, 
the expression level was much higher in fetal tissues than 
in adult ones. Studies using cell cultures showed that a 
selenoprotein N higher expression is found in prolifer-
ating fibroblasts and is progressively decreased during 
the differentiation steps to myoblasts and then myotube 
formation [60]. In addition, the study of selenoprotein 
N  expression  in  zebrafish  embryo  during  early  stages 
of development showed an important expression in the 
notochord, a precursor of the spine, and in the somites 
from which the skeletal muscles differentiate [65]. Col-
lectively, these observations suggest an early develop-
mental expression pattern, in agreement with the early 
onset of the disease. Obtaining animal models disabled 
for the selenoprotein N function should help to explore a 
possible role in muscle formation during development or 
muscle maintenance.
Physiological models
No transgenic animal knocked out for the selenoprotein 
N gene is currently available. On the other hand, analysis 
of  the  dy/dy  mouse  [66],  a  laminin-a2/merosin-defi-
cient animal model of congenital muscular dystrophy, 
highlighted  an  interesting  aspect  [67].  Selenocysteine 
insertion  into  proteins  is  mediated  by  a  specific  se-
lenocysteine transfer RNA (tRNA
sec) (for review, [5]). In 
muscle tissues from these dystrophic animals, the ratio 
of selenocysteine tRNA
sec to serine tRNA
ser significantly 
increased compared with normal mice. This modification 
was concomitant with a higher content in the selenoen-
zyme glutathione peroxidase [67]. Whether this higher 
amount of glutathione peroxidase in affected muscles is 
used to prevent the enhanced oxidative stress caused by 
the dystrophic condition is still unclear.
Removal of the selenocysteine tRNA
sec gene in knock-
out mice is embryogenic lethal at an early stage [68], 
stressing  the  importance  of  selenoprotein  synthesis  to 
early mammalian development. To further investigate the 
role of selenium at the physiological level, an alterna-
tive selenoprotein-deficient mouse model was obtained 
by insertion into the mouse genome of 20 copies of a 
mutant selenocysteine tRNA
sec gene whose transcription 
product lacks 6-isopentenyladenosine, a modified base 
essential for its optimal activity [69]. Overexpression of 
this dominant negative-acting mutant tRNA
sec interfered 
with  normal  selenoprotein  synthesis  in  a  protein-  and 
tissue-specific manner [70, 71]. As expected, these mice 
presented  reduced  levels  of  several  selenoproteins  in 
different tissues. The mice were phenotypically normal 
with respect to skeletal muscles, but the muscles became 
heavier after extensive exercise, compared with normal 
mice, as a result of the amplification of the adaptative 
response to effort [72].
The latter observation is relevant to the provocative hy-
pothesis made by Moosmann and Behl [73], based on 
the observation that the use of statins in prevention and 
treatment of hypercholesterolaemia and coronary heart 
disease causes side effects such as painful responsiveness 
to muscle exercises and myopathy-like syndromes. These 
symptoms are similar to those of the muscle pathology 
associated with selenium deficiency. The authors sug-
gested that molecules of the statin family might interfere 
with the enzymatic isopentenylation of tRNA
sec and thus 
inhibit its maturation to a functional tRNA, resulting in a 
defect in selenoprotein synthesis and subsequent muscle 
disorders.
Perspectives
Accumulation of clinical data over several decades has 
provided much evidence for the essential role of selenium 
in human health, including muscle diseases. However, its 
precise role and the functional relevance of its biological-
ly active form, the selenoproteins, in muscle formation, 
function and maintenance remains unclear. Interpretation 
of clinical results is often complicated by the fact that 
several observations and conclusions are contradictory 
owing to partial information or the limited number of 
patients analyzed. Biochemical studies have shed some 
light on this field; the discovery of selenoprotein N and 
W functions, and other selenoproteins of unknown func-
tions, both at the molecular and physiological levels, will 
provide a new basis for defining the conditions leading to 
the onset of muscular disorders. The enhanced oxidative 
environment caused by the dystrophic status in muscle 
tissues is currently poorly understood, but the dual in-
tervention of selenium and vitamin E suggests a possible 
mechanism to be elucidated. Among the numerous un-
answered questions, one of the most intriguing concerns 
the ubiquitous expression of the SEPN1 gene, an obser-
vation rather unexpected considering the muscle-specific 
disorder associated with mutations in this gene. One can 
hypothesize  that  this  protein  is  involved  in  a  general 
metabolic  pathway,  such  as  protein  post-translational 
modification,  but  that  this  reaction  is  rate  limiting  or 
shows a more dramatic incidence in this tissue because 
of muscle-specific substrate(s).
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